Skip to main content

Advertisement

SpringerLink
Log in

Cerebrovascular Complications and Polycythaemia Vera

  • Letter to the Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Falanga A, Marchetti M (2012) Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program 2012:571–581. https://doi.org/10.1182/asheducation-2012.1.571 2012/1/571

    Article  PubMed  Google Scholar 

  2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

  3. Tefferi A (2012) Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87(3):285–293. https://doi.org/10.1002/ajh.23135

    Article  PubMed  Google Scholar 

  4. Zoraster RM, Rison RA (2013) Acute embolic cerebral ischemia as an initial presentation of polycythemia vera: a case report. J Med Case Rep 7:131. https://doi.org/10.1186/1752-1947-7-131

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sanahuja J, Marti-Fabregas J, Marti-Vilalta JL (2005) Carotid thrombus and cerebral infarction as the initial clinical manifestation of polycythemia vera. Neurologia 20(4):194–196

    CAS  PubMed  Google Scholar 

  6. Arboix A, Besses C (1997) Cerebrovascular disease as the initial clinical presentation of haematological disorders. Eur Neurol 37(4):207–211

    Article  CAS  PubMed  Google Scholar 

  7. Abdel-Rahman I, Murphy C (2015, 2015) Recurrent ischaemic stroke unveils polycythaemia vera. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-207625

  8. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR, Cancer Genome P (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365(9464):1054–1061. https://doi.org/10.1016/S0140-6736(05)71142-9

    Article  CAS  PubMed  Google Scholar 

  9. Tefferi A (2013) Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88(6):507–516. https://doi.org/10.1002/ajh.23417

    Article  CAS  PubMed  Google Scholar 

  10. Vokó Z, Széles G, Kardos L, Németh R, Ádány R (2008) The epidemiology of cerebrovascular diseases in Hungary after the millennium. LAM ( Lege Artis Medicinae) 18(1):31–38

    Google Scholar 

  11. Adams BD, Baker R, Lopez JA, Spencer S (2010) Myeloproliferative disorders and the hyperviscosity syndrome. Hematol Oncol Clin North Am 24(3):585–602. https://doi.org/10.1016/j.hoc.2010.03.004

    Article  PubMed  Google Scholar 

  12. Santisakultarm TP, Paduano CQ, Stokol T, Southard TL, Nishimura N, Skoda RC, Olbricht WL, Schafer AI, Silver RT, Schaffer CB (2014) Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging. J Thromb Haemost. https://doi.org/10.1111/jth.1273

Download references

Acknowledgements

The authors express their thanks to the Institute of Medical Genetics, University of Szeged and to the Institute of Laboratory Medicine, University of Szeged for diagnostic tests.

Author information

Authors and Affiliations

  1. 2nd Department of Medicine and Cardiology Centre, Medical Faculty, Albert Szent-Györgyi Clinical Centre, University of Szeged, Semmelweis 8, Szeged, Hungary

    Imelda Marton, Éva Pósfai & Zita Borbényi

  2. Department of Radiology, Medical Faculty, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

    Angéla Csomor

  3. Department of Neurology, Medical Faculty, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

    László Vécsei & Katalin Sas

  4. Neuroscience Research Group of the Hungarian Academy of Sciences and the University of Szeged, Szeged, Hungary

    László Vécsei

Authors
  1. Imelda Marton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Éva Pósfai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angéla Csomor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. László Vécsei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zita Borbényi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katalin Sas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Imelda Marton.

Ethics declarations

Conflicts of Interest

None declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marton, I., Pósfai, É., Csomor, A. et al. Cerebrovascular Complications and Polycythaemia Vera. Pathol. Oncol. Res. 25, 439–442 (2019). https://doi.org/10.1007/s12253-017-0329-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-017-0329-9

Search

Navigation